A period of austerity public spending in England to note the changes in frailty in individuals aged 50 years and above.
SFDA approves Amarin’s VASCEPA to reduce cardiovascular risk
VASCEPA capsules are indicated for use in patients at increased risk of cardiovascular events caused by at least one other CV disease risk factor. Credit: